New Jersey Plans HMO Regulations

17 March 1997

The New Jersey state legislature's two health committees have approveda bill to strengthen regulations on Health Maintenance Organizations which took effect on March 15, and also extend those protections to other types of insurance plans such as point-of-service and preferred provider programs.

The Health Care Quality Act would: create a new state appeals board to deal with patients or doctors who challenge managed care decisions; raise the fines the state Health Department can levy for some violations; require HMOs to allow customers the option of going outside the provider network, if they pay extra for it; and ban HMOs from offering doctors financial incentives to limit care. The bill now goes to the Legislature for a vote.

The new HMO regulations taking effect March 15 guarantee consumers a choice of specialists and the right to know how an insurer pays its doctors, sets up an appeals process for rejected claims and does away with gag rules. Under the new rules, the Health Department will produce a series of HMO report cards.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight